Options Trading News

January 10, 2014  Fri 12:21 PM CT

Bristol-Myers Squibb has been running hard, and the bulls are getting greedy.

optionMONSTER's Heat Seeker monitoring system detected the purchase of about 30,000 February 57.50 calls for an average premium of $1.50. Some 22,000 January 52.50 calls were sold for $3.35 in volume below the previous open interest, so it appears that an existing long-call position was closed and rolled to a higher strike.

The investor recovered $2.87 million of his or her capital by making the adjustment and now has an additional month to profit from gains in the drug maker. The trader also increased the number of contracts in the position, which will boost leverage if the stock continues to rally. (See our Education section for more on how to manage trades more effectively with options.)

BMY is up 1.64 percent to $55.94 in afternoon trading, its highest price since 2001. The stock has been running in the last month after the company sold its stake in a diabetes-drug joint venture to AstraZeneca. It also reported strong earnings and positive data on a potential cancer drug in October.

Total option volume is quadruple the daily average so far today, with calls outnumbering puts by a bullish 9-to-1 ratio.
Share this article with your friends

Related Stories


Show of support for Bristol-Myers

November 6, 2015

The drug maker is near its 200-day moving average and reported strong earnings last month, which could make some chart watchers think that downside will be limited.


Premium Services

Education & Strategy

The art of trading

As I stated in last week's article, a break out or a break down needs to have a couple things happen before it is considered a confirmed break out or break down. The only problem is that in today's market where things move much more quicker than they did just a few years ago, two days could wind up being the majority of the expected movement, if not the whole movement.

View more education articles »